Author

A.-F. Tabaran

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Borgatti· 1 shared A. Chehadeh· 1 shared A. L. Sarver· 1 shared A. Winter· 1 shared C. Preusser· 1 shared D. Groschen· 1 shared G. R. Cutter· 1 shared I. Cornax· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Borgatti

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Neoadjuvant systemic oncolytic vesicular stomatitis virus is safe and may enhance long-term survivorship in dogs with naturally occurring osteosarcoma.

K. M. Makielski, A. L. Sarver, M. S. Henson, K. M. Stuebner, A. Borgatti, L. Suksanpaisan, C. Preusser, A.-F. Tabaran, I. Cornax, M. G. O'Sullivan, A. Chehadeh, D. Groschen, K. Bergsrud, S. Pracht, A. Winter, , S. Naik

This study evaluates neoadjuvant oncolytic virus therapy in dogs with osteosarcoma, finding it safe and associated with increased long-term survivorship and immune gene expression.

bioRxiv · Apr 16, 2023Cancer Biology